ABVC BIOPHARMA, INC.
Recent Filings
All 778 filings →| Form | Description | Date |
|---|---|---|
| POS AM | POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1 | Mar 27, 2026 |
| 8-K | CURRENT REPORT | Mar 27, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Mar 5, 2026 |
| 10-K | ANNUAL REPORT | Mar 3, 2026 |
| 10-Q/A | AMENDMENT NO. 1 TO FORM 10-Q | Mar 3, 2026 |
| 8-K | CURRENT REPORT | Mar 3, 2026 |
| PRE 14A | PRELIMINARY PROXY STATEMENT | Feb 5, 2026 |
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | Jan 16, 2026 |
| 424B4 | PROSPECTUS SUPPLEMENT | Nov 14, 2025 |
| 424B4 | PROSPECTUS SUPPLEMENT | Nov 14, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Stolz Kevin Patrick | VP & Controller | Award / Grant | 6,250 | 6,250 | Jan 27, 2012 |
| Nirta Joseph | — | Purchase | 10,000 @ $0.15 | 10,000 | Mar 22, 2010 |
| Smith J.B. | — | Purchase | 714,286 @ $50,000.00 | 16,585,538 | Nov 13, 2009 |
| Crockett Robert G | Chief Executive Officer | Award / Grant | 670,000 @ $0.51 | 1,000,000 | Sep 21, 2009 |
| IANNOTTI DANIEL V | VP, General Counsel & Secretar | Award / Grant | 70,000 @ $0.51 | 400,000 | Sep 21, 2009 |
| Krotine Frank Thomas | President & COO | Award / Grant | 169,000 @ $0.51 | 510,217 | Sep 21, 2009 |
| Smith J.B. | — | Purchase | 192,308 @ $50,000.00 | 17,349,752 | Aug 31, 2009 |
| Smith J.B. | — | Purchase | 192,308 @ $50,000.00 | 18,430,752 | Aug 31, 2009 |
| Smith J.B. | — | Purchase | 20 @ $20,000.00 | 336 | Jun 10, 2009 |
| Smith J.B. | — | Purchase | 55 @ $55,000.00 | 2,436 | Jun 2, 2009 |